Academic Journal
Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records.
| العنوان: | Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records. |
|---|---|
| المؤلفون: | Young, Joel L, Powell, Richard N, Powell, Anna, Welling, Lisa L M, Granata, Lauren, Saal, Jaime, Nash, Margot |
| المصدر: | BMC Psychiatry ; ISSN:1471-244X ; Volume:25 ; Issue:1 |
| بيانات النشر: | BioMed Central |
| سنة النشر: | 2025 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | ADHD, Adult treatment, Amphetamine, Extended-release, Immediate-release, Methylphenidate, Regression analysis |
| الوصف: | Adults with ADHD benefit from treatment with extended-release (ER) formulations that provide symptom control for the entire day. Some patients are advised to supplement their extended-release medication with an immediate-release (IR) medication later in the day if they need to prolong its effects. Given that several FDA-approved ER formulations are available and many individual patient variables may affect efficacy, the purpose of this study was to identify reliable predictors of the tendency for patients to supplement their daily ER medication with an IR medication. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | https://doi.org/10.1186/s12888-024-06446-z; https://pubmed.ncbi.nlm.nih.gov/39754122 |
| DOI: | 10.1186/s12888-024-06446-z |
| الاتاحة: | https://doi.org/10.1186/s12888-024-06446-z https://pubmed.ncbi.nlm.nih.gov/39754122 |
| Rights: | © 2024. The Author(s). |
| رقم الانضمام: | edsbas.DD7B6E32 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1186/s12888-024-06446-z |
|---|